Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
alk positive nsclc treatment guidelines | 0.67 | 0.9 | 1324 | 20 | 39 |
alk | 1.74 | 0.7 | 8303 | 80 | 3 |
positive | 0.08 | 0.4 | 4031 | 13 | 8 |
nsclc | 0.25 | 0.1 | 2116 | 73 | 5 |
treatment | 1.03 | 0.2 | 4387 | 28 | 9 |
guidelines | 0.77 | 0.1 | 6122 | 81 | 10 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
alk positive nsclc treatment guidelines | 1.53 | 0.4 | 1407 | 3 |
drugs approved for nsclc alk positive | 0.73 | 0.3 | 252 | 26 |
positive alk nsclc medication | 1.08 | 0.2 | 2367 | 32 |
alk-positive nsclc | 1.56 | 0.4 | 3396 | 99 |
alk nsclc treatment post alectinib | 1.58 | 0.2 | 6596 | 43 |
alk nsclc treatment lung cancer 1st clues | 0.79 | 0.8 | 3020 | 77 |
treatment guidelines for nsclc | 1.1 | 0.5 | 8963 | 81 |
alk+ nsclc | 1.96 | 0.9 | 5543 | 39 |
nsclc treatment guidelines australia | 1.92 | 0.6 | 9541 | 42 |
alectinib for alk+ nsclc | 0.84 | 1 | 9780 | 17 |
alk positive lung cancer treatment | 0.5 | 0.7 | 1258 | 65 |
alk+ nsclc survival rate | 1.79 | 0.1 | 6229 | 53 |
positive alk nsclc medication brexpiprazole | 0.22 | 1 | 9216 | 84 |
treatment for advanced nsclc | 1.3 | 0.6 | 6115 | 66 |
new treatment options for advanced nsclc | 0.73 | 0.2 | 3902 | 54 |
common signs alk nsclc lung cancer treatment | 1.66 | 0.3 | 6458 | 48 |
nsclc treatment guidelines nccn | 0.04 | 0.4 | 6880 | 32 |
alk negative lung cancer treatment | 1.79 | 0.1 | 7621 | 59 |
alk positive cancer report | 1.87 | 0.8 | 6205 | 59 |
treatment of nsclc by stage | 0.58 | 0.6 | 9327 | 63 |
nccn guidelines for nsclc | 0.88 | 0.1 | 3160 | 11 |